FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2001782289> ?p ?o ?g. }

• W2001782289 endingPage "149" @default.
• W2001782289 startingPage "138" @default.
• W2001782289 abstract "This study assessed the efficacy, tolerability and safety of vortioxetine versus placebo in adults with recurrent major depressive disorder. This double-blind, randomized, placebo-controlled study included 608 patients [Montgomery–Åsberg Depression Rating Scale (MADRS) total score≥26 and Clinical Global Impression – Severity score≥4]. Patients were randomly assigned (1 : 1 : 1 : 1) to vortioxetine 15 mg/day, vortioxetine 20 mg/day, duloxetine 60 mg/day or placebo. The primary efficacy endpoint was change from baseline in MADRS total score at week 8 (mixed model for repeated measurements). Key secondary endpoints were: MADRS responders; Clinical Global Impression – Improvement scale score; MADRS total score in patients with baseline Hamilton Anxiety Rating Scale ≥20; remission (MADRS≤10); and Sheehan Disability Scale total score at week 8. On the primary efficacy endpoint, both vortioxetine doses were statistically significantly superior to placebo, with a mean difference to placebo (n=158) of −5.5 (vortioxetine 15 mg, P<0.0001, n=149) and −7.1 MADRS points (vortioxetine 20 mg, P<0.0001, n=151). Duloxetine (n=146) separated from placebo, thus validating the study. In all key secondary analyses, both vortioxetine doses were statistically significantly superior to placebo. Vortioxetine treatment was well tolerated; common adverse events (incidence≥5%) were nausea, headache, diarrhea, dry mouth and dizziness. No clinically relevant changes were seen in clinical safety laboratory values, weight, ECG or vital signs parameters. Vortioxetine was efficacious and well tolerated in the treatment of patients with major depressive disorder." @default.
• W2001782289 created "2016-06-24" @default.
• W2001782289 creator A5003176851 @default.
• W2001782289 creator A5004931783 @default.
• W2001782289 creator A5050375558 @default.
• W2001782289 date "2014-05-01" @default.
• W2001782289 modified "2023-10-14" @default.
• W2001782289 title "Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day" @default.
• W2001782289 cites W143336295 @default.
• W2001782289 cites W1570504112 @default.
• W2001782289 cites W1924063373 @default.
• W2001782289 cites W1987514922 @default.
• W2001782289 cites W1987560991 @default.
• W2001782289 cites W1988763037 @default.
• W2001782289 cites W1993810702 @default.
• W2001782289 cites W1994717858 @default.
• W2001782289 cites W2004762037 @default.
• W2001782289 cites W2011606125 @default.
• W2001782289 cites W2022191212 @default.
• W2001782289 cites W2036812642 @default.
• W2001782289 cites W2048026164 @default.
• W2001782289 cites W2051198709 @default.
• W2001782289 cites W2054766240 @default.
• W2001782289 cites W2056454671 @default.
• W2001782289 cites W2059274457 @default.
• W2001782289 cites W2061669920 @default.
• W2001782289 cites W2061693930 @default.
• W2001782289 cites W2063225659 @default.
• W2001782289 cites W2066283885 @default.
• W2001782289 cites W2084170778 @default.
• W2001782289 cites W2089659183 @default.
• W2001782289 cites W2131823335 @default.
• W2001782289 cites W2146659162 @default.
• W2001782289 cites W2160070901 @default.
• W2001782289 cites W2164182651 @default.
• W2001782289 cites W2038130137 @default.
• W2001782289 doi "https://doi.org/10.1097/yic.0000000000000018" @default.
• W2001782289 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3979887" @default.
• W2001782289 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24257717" @default.
• W2001782289 hasPublicationYear "2014" @default.
• W2001782289 type Work @default.
• W2001782289 sameAs 2001782289 @default.
• W2001782289 citedByCount "137" @default.
• W2001782289 countsByYear W20017822892014 @default.
• W2001782289 countsByYear W20017822892015 @default.
• W2001782289 countsByYear W20017822892016 @default.
• W2001782289 countsByYear W20017822892017 @default.
• W2001782289 countsByYear W20017822892018 @default.
• W2001782289 countsByYear W20017822892019 @default.
• W2001782289 countsByYear W20017822892020 @default.
• W2001782289 countsByYear W20017822892021 @default.
• W2001782289 countsByYear W20017822892022 @default.
• W2001782289 countsByYear W20017822892023 @default.
• W2001782289 crossrefType "journal-article" @default.
• W2001782289 hasAuthorship W2001782289A5003176851 @default.
• W2001782289 hasAuthorship W2001782289A5004931783 @default.
• W2001782289 hasAuthorship W2001782289A5050375558 @default.
• W2001782289 hasBestOaLocation W20017822891 @default.
• W2001782289 hasConcept C118552586 @default.
• W2001782289 hasConcept C126322002 @default.
• W2001782289 hasConcept C142724271 @default.
• W2001782289 hasConcept C15744967 @default.
• W2001782289 hasConcept C197934379 @default.
• W2001782289 hasConcept C203092338 @default.
• W2001782289 hasConcept C204787440 @default.
• W2001782289 hasConcept C27081682 @default.
• W2001782289 hasConcept C2776000289 @default.
• W2001782289 hasConcept C2778034309 @default.
• W2001782289 hasConcept C2778375690 @default.
• W2001782289 hasConcept C2780051608 @default.
• W2001782289 hasConcept C2780580376 @default.
• W2001782289 hasConcept C2780733359 @default.
• W2001782289 hasConcept C2780764818 @default.
• W2001782289 hasConcept C2910564767 @default.
• W2001782289 hasConcept C42219234 @default.
• W2001782289 hasConcept C535046627 @default.
• W2001782289 hasConcept C71924100 @default.
• W2001782289 hasConceptScore W2001782289C118552586 @default.
• W2001782289 hasConceptScore W2001782289C126322002 @default.
• W2001782289 hasConceptScore W2001782289C142724271 @default.
• W2001782289 hasConceptScore W2001782289C15744967 @default.
• W2001782289 hasConceptScore W2001782289C197934379 @default.
• W2001782289 hasConceptScore W2001782289C203092338 @default.
• W2001782289 hasConceptScore W2001782289C204787440 @default.
• W2001782289 hasConceptScore W2001782289C27081682 @default.
• W2001782289 hasConceptScore W2001782289C2776000289 @default.
• W2001782289 hasConceptScore W2001782289C2778034309 @default.
• W2001782289 hasConceptScore W2001782289C2778375690 @default.
• W2001782289 hasConceptScore W2001782289C2780051608 @default.
• W2001782289 hasConceptScore W2001782289C2780580376 @default.
• W2001782289 hasConceptScore W2001782289C2780733359 @default.
• W2001782289 hasConceptScore W2001782289C2780764818 @default.
• W2001782289 hasConceptScore W2001782289C2910564767 @default.
• W2001782289 hasConceptScore W2001782289C42219234 @default.
• W2001782289 hasConceptScore W2001782289C535046627 @default.
• W2001782289 hasConceptScore W2001782289C71924100 @default.
• W2001782289 hasIssue "3" @default.
• W2001782289 hasLocation W20017822891 @default.

• next